How big is the Anti-obesity Drugs Market?

The Anti-obesity Drugs Market size is expected to reach USD 13.01 billion in 2024 and grow at a CAGR of 16.53% to reach USD 27.95 billion by 2029. Read More

What is the current Anti-obesity Drugs Market size?

In 2024, the Anti-obesity Drugs Market size is expected to reach USD 13.01 billion. Read More

Who are the key players in Anti-obesity Drugs Market?

Vivus, F Hoffmann-La Roche AG, GlaxoSmithKline PLC, Novo Nordisk AS and Currax Pharmaceuticals LLC are the major companies operating in the Anti-obesity Drugs Market. Read More

Which is the fastest growing region in Anti-obesity Drugs Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Anti-obesity Drugs Market?

In 2024, the North America accounts for the largest market share in Anti-obesity Drugs Market. Read More

What years does this Anti-obesity Drugs Market cover, and what was the market size in 2023?

In 2023, the Anti-obesity Drugs Market size was estimated at USD 10.86 billion. The report covers the Anti-obesity Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Anti-obesity Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Anti-Obesity Drugs Market - Trends, Analysis & Share

Anti-Obesity Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Anti Obesity Drugs Market Size & Statistics and It is Segmented by Mechanism of Action (Peripherally Acting Drugs and Centrally Acting Drugs), Drug Type (Prescription Drugs and OTC Drugs), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The Market Size and Forecasts are Provided in Terms of Value (USD Million) for the Above Segments.

Anti-Obesity Drugs Industry Overview

The anti-obesity drug market is moderated due to the presence of companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold a significant market share and are well known, including GlaxoSmithKline PLC, Novo Nordisk AS, Pfizer Inc., F. Hoffmann-La Roche AG, and Bayer AG.